Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200
ClinicalTrials.gov study NCT00455910. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load
ClinicalTrials.gov study NCT00452660. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB)
ClinicalTrials.gov study NCT04326023. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Development and Prospective Validation of a Standardized Flow Cytometric Assay of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes.
ClinicalTrials.gov study NCT04399018. IPD Sharing: YES. Countries: 1. Publications: 2.
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00005823. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04402541. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
ClinicalTrials.gov study NCT00903422. IPD Sharing: Not stated. Countries: 11. Publications: 2.
A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00283114. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06399640. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.
ClinicalTrials.gov study NCT01868477. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Mean Platelet Volume and Its Relation to Risk Stratification of Myelodysplastic Syndromes
ClinicalTrials.gov study NCT05204953. IPD Sharing: Not stated. Countries: 0. Publications: 6.
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00778375. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Ei
ClinicalTrials.gov study NCT00045942. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01894477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT05703542. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02269280. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00480987. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SB1518 for Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01436084. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT01486784. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00818649. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.